Skip to main content
. 2016 Jul 9;30(9):807–818. doi: 10.1007/s40263-016-0367-y
In light of recent concerns about extrapyramidal symptoms (EPS) as a potential side effect of aripiprazole, we conducted a meta-analysis to assess the incidence of EPS in children and adolescents.
We found a mean incidence of 17.1 % (95 % confidence interval 0.128–0.223).
This finding highlights the importance of considerate prescription of aripiprazole in youth.